FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

425753008: Conventional release cutaneous ointment (dose form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2675420017 Cutaneous ointment en Synonym Active Entire term case insensitive SNOMED CT core module
3541117017 Conventional release cutaneous ointment (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3541118010 Conventional release cutaneous ointment en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Conventional release cutaneous ointment Is a Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Conventional release cutaneous ointment Is a Ointment false Inferred relationship Existential restriction modifier
Conventional release cutaneous ointment Is a Cutaneous dose form true Inferred relationship Existential restriction modifier
Conventional release cutaneous ointment Has dose form administration method Apply true Inferred relationship Existential restriction modifier
Conventional release cutaneous ointment Has dose form intended site Cutaneous true Inferred relationship Existential restriction modifier
Conventional release cutaneous ointment Has dose form release characteristic Conventional release true Inferred relationship Existential restriction modifier
Conventional release cutaneous ointment Has basic dose form Ointment true Inferred relationship Existential restriction modifier
Conventional release cutaneous ointment Has dose form transformation No transformation true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely retapamulin 10 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely sodium fusidate 20 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely tacalcitol (as tacalcitol monohydrate) 4 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely lactic acid 250 milligram/1 gram and salicylic acid 250 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely salicylic acid 500 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Salicylic acid in white soft paraffin 60%/40% ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Chlortetracycline hydrochloride 3% ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely nystatin 100000 unit/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Gentamicin sulfate 0.1% ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely nystatin 100 unit/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely erythromycin 20 microgram/1 milligram conventional release cutaneous ointment (clinical drug) Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely bacitracin 500 unit/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely prednicarbate 1 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Miconazole 0.25%/zinc oxide 15%/white petrolatum 81.35% topical ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Catechin 15% topical ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely dithranol 10 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely glyceryl trinitrate 20 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely mineral oil 500 milligram/1 gram and white petrolatum 500 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely cod liver oil 114 milligram/1 gram and zinc oxide 380 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Chamomile extracts 10.5% ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone 25 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone acetate 10 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely clioquinol 30 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone 10 milligram/1 gram and oxytetracycline (as oxytetracycline hydrochloride) 30 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone acetate 10 milligram/1 gram and sodium fusidate 20 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone 10 milligram/1 gram and miconazole nitrate 20 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely alclometasone dipropionate 500 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely beclometasone dipropionate 250 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Betamethasone 0.1% ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and salicylic acid 30 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone dipropionate) 500 nanogram/1 milligram conventional release cutaneous ointment (clinical drug) Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely clobetasone butyrate 500 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely diflucortolone valerate 1 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely diflucortolone valerate 3 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely fluocinonide 500 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Fluocortolone 0.5% ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely fludroxycortide 125 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely clorquinaldol 30 milligram/1 gram and hydrocortisone butyrate 1 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone butyrate 1 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely mometasone furoate 1 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely fluticasone propionate 50 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely coal tar 10 milligram/1 gram and dithranol 1.1 milligram/1 gram and salicylic acid 16 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely calcipotriol 50 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely Podophyllum resin 200 milligram/1 gram and salicylic acid 250 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely lithium succinate 80 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely mupirocin 20 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely povidone iodine 100 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely cinchocaine hydrochloride 11 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely clobetasol propionate 500 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone 10 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely benzalkonium chloride 1 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone 5 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely neomycin 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely cinchocaine 10 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Betamethasone dipropionate 0.5mg/g ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely triamcinolone acetonide 1 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely fludroxycortide 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely fludroxycortide 500 microgram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely amcinonide 1 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely chloramphenicol (as chloramphenicol sodium succinate) 10 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely desonide 500 microgram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely halcinonide 1 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely desoximetasone 2.5 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone valerate 2 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely erythromycin 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Betamethasone dipropionate 0.5% ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely aciclovir 50 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 8 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Lignocaine 5% / Hydrocortisone acetate 0.275% ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely mineral oil 50 milligram/1 gram and white petrolatum 950 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely tacrolimus (as tacrolimus monohydrate) 1 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely calcitriol 3 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Lidocaine 2.5% topical ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely salicylic acid 600 milligram/1 gram and white petrolatum 400 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form True Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely tetracycline 10 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone dipropionate) 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely miconazole nitrate 2.5 milligram/1 gram and zinc oxide 150 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely lidocaine hydrochloride 25 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely chlortetracycline 30 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone acetate 2.75 milligram/1 gram and lidocaine hydrochloride 50 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely fluocortolone caproate 2.5 milligram/1 gram and fluocortolone pivalate 2.5 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely gentamicin (as gentamicin sulfate) 1 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely betamethasone valerate 1 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely crisaborole 20 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely tirbanibulin 10 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely tacrolimus 300 microgram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely tacrolimus 1 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely tacalcitol 4 microgram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely clobetasol propionate 500 microgram/1 gram and gentamicin (as gentamicin sulfate) 1 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely lysine hydrochloride 150 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely miconazole nitrate 20 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form True Conventional release cutaneous ointment Inferred relationship Existential restriction modifier

Page 1 of 3 Next End

This concept is not in any reference sets

Back to Start